These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 17274353
1. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats. Benchetrit S, Yarkoni S, Rathaus M, Pines M, Rashid G, Bernheim J, Bernheim J. Isr Med Assoc J; 2007 Jan; 9(1):30-4. PubMed ID: 17274353 [Abstract] [Full Text] [Related]
2. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 Jan; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
3. Effect of chronic tetrahydrobiopterin supplementation on blood pressure and proteinuria in 5/6 nephrectomized rats. Podjarny E, Hasdan G, Bernheim J, Rashid G, Green J, Korzets Z, Bernheim J. Nephrol Dial Transplant; 2004 Sep; 19(9):2223-7. PubMed ID: 15252157 [Abstract] [Full Text] [Related]
4. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of pancreatic fibrosis in an experimental model of severe hyperstimulation and obstruction pancreatitis. Karatas A, Paksoy M, Erzin Y, Carkman S, Gonenc M, Ayan F, Aydogan F, Uzun H, Durak H. J Surg Res; 2008 Jul; 148(1):7-12. PubMed ID: 18570924 [Abstract] [Full Text] [Related]
5. Castration attenuates proteinuria and glomerular injury in unilaterally nephrectomized male Sprague-Dawley rats. Sakemi T, Baba N. Lab Invest; 1993 Jul; 69(1):51-7. PubMed ID: 8331899 [Abstract] [Full Text] [Related]
6. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. J Am Soc Nephrol; 2007 Feb; 18(2):528-38. PubMed ID: 17202414 [Abstract] [Full Text] [Related]
7. Electroacupuncture and moxibustion attenuate the progression of renal disease in 5/6 nephrectomized rats. Paterno JC, Freire AO, Soares MF, Franco MF, Schor N, Teixeira VP. Kidney Blood Press Res; 2008 Feb; 31(6):367-73. PubMed ID: 19033712 [Abstract] [Full Text] [Related]
8. The antifibrotic drug halofuginone reduces ischemia/reperfusion-induced oxidative renal damage in rats. Karadeniz Cerit K, Karakoyun B, Yüksel M, Özkan N, Cetinel Ş, Tolga Dağli E, Yeğen BÇ, Tuğtepe H. J Pediatr Urol; 2013 Apr; 9(2):174-83. PubMed ID: 22373656 [Abstract] [Full Text] [Related]
9. Effect of probucol on mRNA expression of glomerular antioxidant enzymes in rat with subtotal nephrectomy. Tang Z, Ji D, Li L, Fukui M, Tomino Y, Koide H. Chin Med J (Engl); 1996 Oct; 109(10):780-6. PubMed ID: 9275355 [Abstract] [Full Text] [Related]
10. Vitamin E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Tain YL, Freshour G, Dikalova A, Griendling K, Baylis C. Am J Physiol Renal Physiol; 2007 May; 292(5):F1404-10. PubMed ID: 17200156 [Abstract] [Full Text] [Related]
11. Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-beta 1 overexpression in 5/6 nephrectomized rats. Bautista-García P, Sánchez-Lozada LG, Cristóbal-García M, Tapia E, Soto V, Avila-Casado MC, Márquez-Velasco R, Bojalil R, Franco M, Herrera-Acosta J. Nephrol Dial Transplant; 2006 Nov; 21(11):3074-81. PubMed ID: 16935907 [Abstract] [Full Text] [Related]
12. Inhibition of transforming growth factor beta signaling by halofuginone as a modality for pancreas fibrosis prevention. Zion O, Genin O, Kawada N, Yoshizato K, Roffe S, Nagler A, Iovanna JL, Halevy O, Pines M. Pancreas; 2009 May; 38(4):427-35. PubMed ID: 19188864 [Abstract] [Full Text] [Related]
13. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat. Krivosíková Z, Sebeková K, Spustová V, Lajdová I, Dzúrik R. Physiol Res; 1999 May; 48(6):429-35. PubMed ID: 10783907 [Abstract] [Full Text] [Related]
14. Renal failure in high altitude: renal functions, renal pathology and bone mineralization in rats with ablation nephropathy at 1200 m altitude. Soylu A, Kavukçu S, Yilmaz O, Astarcioğlu H, Ozkal S, Türkmen M, Sarioğlu S. Pathol Res Pract; 2007 May; 203(11):795-800. PubMed ID: 17904299 [Abstract] [Full Text] [Related]
15. Effect of a serine protease inhibitor on the progression of chronic renal failure. Hayata M, Kakizoe Y, Uchimura K, Morinaga J, Yamazoe R, Mizumoto T, Onoue T, Ueda M, Shiraishi N, Adachi M, Miyoshi T, Sakai Y, Tomita K, Kitamura K. Am J Physiol Renal Physiol; 2012 Oct 15; 303(8):F1126-35. PubMed ID: 22832926 [Abstract] [Full Text] [Related]
16. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model. Nagler A, Gofrit O, Ohana M, Pode D, Genina O, Pines M. J Urol; 2000 Nov 15; 164(5):1776-80. PubMed ID: 11025768 [Abstract] [Full Text] [Related]
17. Effects of a calcium antagonist, manidipine, on progressive renal injury associated with mild hypertension in remnant kidneys. Kobayashi S, Hishida A. J Lab Clin Med; 1995 May 15; 125(5):572-80. PubMed ID: 7738423 [Abstract] [Full Text] [Related]
18. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet. Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y. Clin Exp Nephrol; 2003 Jun 15; 7(2):113-9. PubMed ID: 14586729 [Abstract] [Full Text] [Related]
19. Effectiveness of topically applied halofuginone in management of subglottic stenosis in rats. Ertuğrul EE, Cekin IE, Cincik H, Doğru S, Güngör A. Otolaryngol Head Neck Surg; 2009 May 15; 140(5):720-3. PubMed ID: 19393418 [Abstract] [Full Text] [Related]
20. Halofuginone can worsen liver fibrosis in bile duct obstructed rats. Van de Casteele M, Roskams T, Van der Elst I, van Pelt JF, Fevery J, Nevens F. Liver Int; 2004 Oct 15; 24(5):502-9. PubMed ID: 15482349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]